Coronavirus in Hematologic Malignancies: Targeting Molecules Beyond the Angiotensin-Converting Enzyme 2 (ACE2) Wall in COVID-19.
Saved in:
| Title: | Coronavirus in Hematologic Malignancies: Targeting Molecules Beyond the Angiotensin-Converting Enzyme 2 (ACE2) Wall in COVID-19. |
|---|---|
| Authors: | Tsiambas E; Department of Cytology, 401 & 417 VA Hospital (NIMTS), Athens, Greece. tsiambasecyto@yahoo.gr.; Department of Pathology, Medical School, National and Kapodistrian University of Athens, 17 Patriarchou Grigoriou E΄ Street, Ag. Paraskevi, 153 41, Athens, Greece. tsiambasecyto@yahoo.gr., Papanikolaou V; 1st ENT Department, Hippocration Hospital, University of Athens, Athens, Greece., Chrysovergis A; 1st ENT Department, Hippocration Hospital, University of Athens, Athens, Greece., Mastronikolis N; Department of Otorhinolaryngology, Head and Neck Surgery, Medical School, University of Patras, Patras, Greece., Ragos V; Department of Maxillofacial Surgery, School of Health Sciences, University of Ioannina, Ioannina, Greece., Kavantzas N; Department of Pathology, Medical School, National and Kapodistrian University of Athens, 17 Patriarchou Grigoriou E΄ Street, Ag. Paraskevi, 153 41, Athens, Greece., Lazaris AC; Department of Pathology, Medical School, National and Kapodistrian University of Athens, 17 Patriarchou Grigoriou E΄ Street, Ag. Paraskevi, 153 41, Athens, Greece., Kyrodimos E; 1st ENT Department, Hippocration Hospital, University of Athens, Athens, Greece. |
| Source: | Pathology oncology research : POR [Pathol Oncol Res] 2020 Oct; Vol. 26 (4), pp. 2823-2825. Date of Electronic Publication: 2020 Apr 24. |
| Publication Type: | Letter |
| Journal Info: | Publisher: Frontiers Media S. A Country of Publication: Switzerland NLM ID: 9706087 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1532-2807 (Electronic) Linking ISSN: 12194956 NLM ISO Abbreviation: Pathol Oncol Res Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
